Neogen Corp SEC filings NEOG
Neogen Corp has 1,000 filings in SEC EDGAR's recent list, going back to Nov 12, 2013. Its latest annual report, Form ARS, was filed on Aug 21, 2026 for the period ended May 31, 2026. The latest quarterly report (Form 10-Q) was filed on Oct 7, 2026, covering the quarter ended Aug 31, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (other events). The company's fiscal year ends on May 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Sep 28, 2026 | — |
| DEFA14A | Additional proxy material | Aug 21, 2026 | — |
| DEF 14A | Proxy statement | Aug 21, 2026 | Aug 21, 2026 |
| DEFA14A | Additional proxy material | Sep 12, 2025 | — |
| DEF 14A | Proxy statement | Sep 12, 2025 | Sep 12, 2025 |
| DEF 14A | Proxy statement | Sep 13, 2024 | Oct 24, 2024 |
| DEF 14A | Proxy statement | Sep 18, 2023 | Oct 25, 2023 |
| DEF 14A | Proxy statement | Aug 30, 2022 | Oct 6, 2022 |
| DEFM14A | Filing | Jul 18, 2022 | — |
| PREM14A | Filing | Mar 18, 2022 | Mar 18, 2022 |
| DEF 14A | Proxy statement | Aug 31, 2021 | Oct 7, 2021 |
| PRE 14A | Preliminary proxy statement | Aug 19, 2021 | Oct 7, 2021 |
| DEF 14A | Proxy statement | Aug 31, 2020 | Oct 8, 2020 |
| DEF 14A | Proxy statement | Aug 27, 2019 | Oct 3, 2019 |
| DEF 14A | Proxy statement | Aug 28, 2018 | Oct 4, 2018 |
| PRE 14A | Preliminary proxy statement | Aug 16, 2018 | Oct 4, 2018 |
| DEF 14A | Proxy statement | Aug 30, 2017 | Oct 5, 2017 |
| DEF 14A | Proxy statement | Aug 31, 2016 | Oct 6, 2016 |
| DEF 14A | Proxy statement | Aug 28, 2015 | Oct 1, 2015 |
| PRE 14A | Preliminary proxy statement | Aug 14, 2015 | Oct 1, 2015 |
| DEF 14A | Proxy statement | Aug 29, 2014 | Oct 2, 2014 |
Showing 21 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- In Vitro & In Vivo Diagnostic Substances (SIC 2835)
- Listed as
- NEOG (Nasdaq)
- Fiscal year ends
- May 31
- Incorporated in
- MI
- Headquarters
- Lansing, MI
- SEC filer status
- Large accelerated filer
- SEC CIK
- 711377
Other In Vitro & In Vivo Diagnostic Substances companies
- Idexx Laboratories Inc /DE IDXX
- Lantheus Holdings, Inc. LNTH
- Celldex Therapeutics, Inc. CLDX
- Intellia Therapeutics, Inc. NTLA
- QuidelOrtho Corp QDEL
- Achieve Life Sciences, Inc. ACHV
- Myriad Genetics Inc MYGN
- Alpha Teknova, Inc. TKNO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.